Three Peak Bio directors resign; board reduced to three members

Peak Bio, Inc.

David Rosenberg, Michael Friedman, and Stephen LaMond resigned from Peak Bio's Board on July 19, 2024, effective immediately.
Resignations for personal reasons; no disagreements with Company operations, policies, or practices.
Board size reduced from six to three members following the departures.
Stephen LaMond remains Interim CEO despite resigning as a director.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Rosenberg

Director

Peak Bio, Inc.

Effective: 2024-07-19
Filed: July 24, 2024, 7:59 PM ET

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

Departed

Michael Friedman

Director

Peak Bio, Inc.

Effective: 2024-07-19
Filed: July 24, 2024, 7:59 PM ET

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

Departed

Stephen LaMond

Director

Peak Bio, Inc.

Effective: 2024-07-19
Filed: July 24, 2024, 7:59 PM ET

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Rosenberg resigned as Director at Peak Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Friedman resigned as Director at Peak Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen LaMond resigned as Director at Peak Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-086110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.